OUR vPHARMA NETWORK
At rngen, our success is built on the strength of our ()—a dynamic ecosystem of partners, collaborators, and industry leaders driving our innovation in drug discovery and development. By leveraging a distributed yet highly integrated approach, we maximize efficiency, reduce overhead, and accelerate the path from concept to clinic. Our model allows us to combine world-class expertise across biotechnology, academia, artificial intelligence, regulatory affairs, and clinical research, ensuring we remain agile and at the forefront of pharmaceutical innovation.
The is rngen’s virtual powerhouse—linking almost 30 expert collaborators across the therapeutic pipeline, from discovery to delivery. This lean, virtual infrastructure gives rngen speed, agility, and deep domain expertise without the drag of legacy pharma.
Every partner within our network plays a critical role in shaping the future of therapeutics—from early-stage research and preclinical validation to manufacturing, regulatory navigation, and clinical trials. This collaborative infrastructure is what enables rngen to rapidly advance first-in-class peptide-based therapeutics and small molecule drugs for unmet medical needs. Below, we highlight the key categories of our , demonstrating the depth and breadth of expertise that fuels our mission.
Case Western Reserve University is a nationally recognized research university known for its strengths in medicine, engineering, and biomedical innovation. Collaborating with Prof. Rita Ryan (Pediatrics, School of Medicine) on preclinical animal studies for our SBIR R44 grant in bronchopulmonary dysplasia.
The Medical College of Wisconsin is a nationally recognized academic medical center known for research excellence in pediatrics, neuroscience, and translational medicine. Collaborating with Prof. Ru-Jeng Teng (BPD) and Prof. Kirkwood Pritchard (SCD) on SBIR-funded studies in neonatology and sickle cell disease.
Concordia University Wisconsin is a private Lutheran university known for its strong programs in pharmacy and biomedical sciences. Working with Profs. Chris Cunningham and Dan Sem (School of Pharmacy) on molecular modeling and drug discovery.
University of California, Irvine is a top-tier public research university known for excellence in biomedical science and innovation. Collaborating with Prof. Kalpna Gupta (Pain Research) on our R44 SBIR grant to study sickle cell disease.
Université de Sherbrooke is a leading research university in Quebec, Canada, with strong programs in pharmacology and biomedical sciences. Working with Prof. Pierre-Luc Boudreault (Pharmacology) to synthesize novel SCPD compounds for rngen’s therapeutic library.
Versiti is a nationally recognized leader in blood health innovation, specializing in hematology, immunology, and translational research. rngen collaborates with Versiti scientists on hematologic disorders and multiple sclerosis to inform therapeutic development and biomarker strategy.
The Medical College of Wisconsin is a nationally recognized academic health center with deep clinical expertise in pediatric and hematologic diseases. rngen works with MCW clinical advisors in bronchopulmonary dysplasia (BPD) and sickle cell disease (SCD) through its Medical Advisory Board.
Children’s Hospital Wisconsin is a nationally recognized pediatric health system known for its excellence in neonatal and critical care. rngen collaborates with leading neonatologists at CHI on bronchopulmonary dysplasia (BPD), supporting both clinical insight and translational alignment for drug development.
Mayo Clinic is a globally renowned academic medical center known for excellence in patient care, research, and clinical innovation. rngen is in the process of partnering with Mayo researchers and clinicians through its SBIR grant program to advance therapies across multiple disease areas.
BMO is a leading North American financial institution offering tailored banking solutions for small and mid-sized businesses. Serves as rngen’s corporate banking partner, providing business checking, treasury services, wire transfers, and access to credit facilities.
Taft Law is a full-service corporate law firm providing legal counsel to emerging and growth-stage companies across the U.S. Supports rngen with corporate structuring, contract negotiation, equity and financing matters, and compliance with state and federal regulations.
Elevate Financial Services is a professional accounting firm providing financial oversight and advisory services to early-stage companies. Manages rngen’s corporate accounting, financial reporting, tax compliance, and strategic budgeting operations.
Boyle & Fredrickson is Wisconsin’s largest intellectual property law firm, specializing in patent, trademark, and copyright law for innovation-driven companies. Provides strategic counsel to rngen on all aspects of IP development, portfolio management, and global patent maintenance.
The Technology Innovation Center is a business incubator located in the Milwaukee County Research Park, supporting young companies with infrastructure and administrative resources. rngen leases office space and utilizes TIC’s on-site services to support day-to-day operations.
Charles River Laboratories is a global CRO offering comprehensive preclinical and clinical services for drug discovery and development. Serves as rngen’s preferred CRO and strategic partner for preclinical studies across multiple therapeutic areas.
aappTec is a leading U.S.-based manufacturer specializing in custom peptide synthesis and peptide production technologies. Produces kilogram-scale batches of KYC for rngen’s toxicology studies and supports synthesis of the rngen Peptoid library of compounds.
AnaSpec is a GMP-certified manufacturer that has supplied us with clinical-grade KYC for preclinical and future IND-enabling studies. They also conducted detailed stability testing to support our regulatory and formulation development efforts.
Comparative Biosciences, Inc. (CBI) is a premier preclinical CRO based in California, specializing in GLP-compliant safety, toxicology, and pathology services. Conducts some of rngen’s preclinical toxicology studies to support IND-enabling regulatory submissions.
RareMoon is a specialized regulatory consultancy with deep expertise in orphan drug development and rare disease strategy. Advising rngen on regulatory pathways and managing interactions with both the FDA and EMA for orphan drug IND approval.
BioModels is a preclinical CRO with deep expertise across a wide range of animal disease models, including inflammation and neurodegeneration. Supports rngen’s in vivo studies for inflammation-based neurological conditions such as multiple sclerosis and ischemic stroke.
gBETA is a nationally ranked startup accelerator offering intensive participatory programs to help early-stage companies gain traction and visibility. Supported rngen by facilitating access to venture capital, private equity, and angel investors.
Bridge to Cures is a Wisconsin-based accelerator supporting early-stage academic entrepreneurs developing innovative healthcare solutions. Served as rngen’s initial investor, providing seed-stage funding to launch its therapeutic development platform.
The National Heart, Lung, and Blood Institute is a major NIH institute focused on advancing research in cardiovascular, pulmonary, and hematologic diseases. Supports rngen’s SBIR-funded programs targeting SCD and BPD.
The National Institute of Neurological Disorders and Stroke leads NIH efforts to reduce the burden of neurological disease through research and innovation. Provides SBIR funding to rngen for development of novel therapies in stroke and multiple sclerosis.
The Center for Technology Commercialization supports Wisconsin-based companies by helping researchers and entrepreneurs bring innovations to market. They have provided matching funds to support rngen’s NIH SBIR grants through the state’s competitive commercialization program.
The Wisconsin Economic Development Corporation is the state’s lead economic agency, advancing business growth and innovation across Wisconsin. Provided operational support and early-stage financing to rngen through strategic loan programs.
The Medical College of Wisconsin is a nationally recognized academic medical center known for research excellence in pediatrics, neuroscience, and translational medicine. MCW also serves as a strategic partner and equity stakeholder in rngen, providing an exclusive worldwide license to foundational KYC intellectual property.
AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, UK, with leadership in cardiovascular, respiratory, and inflammation research. In discussions to explore collaborative development of novel MPO inhibitors targeting inflammatory disease.
Academic Collaborators
-
x
Université de Sherbrooke
Université de Sherbrooke is a leading research university in Quebec, Canada, with strong programs in pharmacology and biomedical sciences. Working with Prof. Pierre-Luc Boudreault (Pharmacology) to synthesize novel SCPD compounds for rngen’s therapeutic library.
View More -
x
University of California - Irvine
University of California, Irvine is a top-tier public research university known for excellence in biomedical science and innovation. Collaborating with Prof. Kalpna Gupta (Pain Research) on our R44 SBIR grant to study sickle cell disease.
View More -
x
Concordia University
Concordia University Wisconsin is a private Lutheran university known for its strong programs in pharmacy and biomedical sciences. Working with Profs. Chris Cunningham and Dan Sem (School of Pharmacy) on molecular modeling and drug discovery.
View More -
x
Case Western Reserve University
Case Western Reserve University is a nationally recognized research university known for its strengths in medicine, engineering, and biomedical innovation. Collaborating with Prof. Rita Ryan (Pediatrics, School of Medicine) on preclinical animal studies for our SBIR R44 grant in bronchopulmonary dysplasia.
View More -
x
Medical College of Wisconsin
The Medical College of Wisconsin is a nationally recognized academic medical center known for research excellence in pediatrics, neuroscience, and translational medicine. Collaborating with Prof. Ru-Jeng Teng (BPD) and Prof. Kirkwood Pritchard (SCD) on SBIR-funded studies in neonatology and sickle cell disease.
View More
Strategic Partner
-
x
Medical College of Wisconsin
The Medical College of Wisconsin is a nationally recognized academic medical center known for research excellence in pediatrics, neuroscience, and translational medicine. MCW also serves as a strategic partner and equity stakeholder in rngen, providing an exclusive worldwide license to foundational KYC intellectual property.
View More -
x
AstraZeneca
AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, UK, with leadership in cardiovascular, respiratory, and inflammation research. In discussions to explore collaborative development of novel MPO inhibitors targeting inflammatory disease.
View More
Operations
-
x
Elevate Financial Services
Elevate Financial Services is a professional accounting firm providing financial oversight and advisory services to early-stage companies. Manages rngen’s corporate accounting, financial reporting, tax compliance, and strategic budgeting operations.
View More -
x
Sherman & Howard and Taft
Taft Law is a full-service corporate law firm providing legal counsel to emerging and growth-stage companies across the U.S. Supports rngen with corporate structuring, contract negotiation, equity and financing matters, and compliance with state and federal regulations.
View More -
x
Boyle Fredrickson
Boyle & Fredrickson is Wisconsin’s largest intellectual property law firm, specializing in patent, trademark, and copyright law for innovation-driven companies. Provides strategic counsel to rngen on all aspects of IP development, portfolio management, and global patent maintenance.
View More -
x
BMO Bank
BMO is a leading North American financial institution offering tailored banking solutions for small and mid-sized businesses. Serves as rngen’s corporate banking partner, providing business checking, treasury services, wire transfers, and access to credit facilities.
View More -
x
Technology Innovation Center - Waukasha
The Technology Innovation Center is a business incubator located in the Milwaukee County Research Park, supporting young companies with infrastructure and administrative resources. rngen leases office space and utilizes TIC’s on-site services to support day-to-day operations.
View More
Service Providers
-
x
Charlesriver
Charles River Laboratories is a global CRO offering comprehensive preclinical and clinical services for drug discovery and development. Serves as rngen’s preferred CRO and strategic partner for preclinical studies across multiple therapeutic areas.
View More -
x
AAPPTec
aappTec is a leading U.S.-based manufacturer specializing in custom peptide synthesis and peptide production technologies. Produces kilogram-scale batches of KYC for rngen’s toxicology studies and supports synthesis of the rngen Peptoid library of compounds.
View More -
x
Anaspec
AnaSpec is a GMP-certified manufacturer that has supplied us with clinical-grade KYC for preclinical and future IND-enabling studies. They also conducted detailed stability testing to support our regulatory and formulation development efforts.
View More -
x
Comparative Biosciences, Inc. (CBI)
Comparative Biosciences, Inc. (CBI) is a premier preclinical CRO based in California, specializing in GLP-compliant safety, toxicology, and pathology services. Conducts some of rngen’s preclinical toxicology studies to support IND-enabling regulatory submissions.
View More -
x
Raremoon
RareMoon is a specialized regulatory consultancy with deep expertise in orphan drug development and rare disease strategy. Advising rngen on regulatory pathways and managing interactions with both the FDA and EMA for orphan drug IND approval.
View More -
x
BioModels
BioModels is a preclinical CRO with deep expertise across a wide range of animal disease models, including inflammation and neurodegeneration. Supports rngen’s in vivo studies for inflammation-based neurological conditions such as multiple sclerosis and ischemic stroke.
View More
Clinical
-
x
Medical College of Wisconsin
The Medical College of Wisconsin is a nationally recognized academic health center with deep clinical expertise in pediatric and hematologic diseases. rngen works with MCW clinical advisors in bronchopulmonary dysplasia (BPD) and sickle cell disease (SCD) through its Medical Advisory Board.
View More -
x
Versiti
Versiti is a nationally recognized leader in blood health innovation, specializing in hematology, immunology, and translational research. rngen collaborates with Versiti scientists on hematologic disorders and multiple sclerosis to inform therapeutic development and biomarker strategy.
View More -
x
Children’s Wisconsin
Children’s Hospital Wisconsin is a nationally recognized pediatric health system known for its excellence in neonatal and critical care. rngen collaborates with leading neonatologists at CHI on bronchopulmonary dysplasia (BPD), supporting both clinical insight and translational alignment for drug development.
View More -
x
Mayo Clinic
Mayo Clinic is a globally renowned academic medical center known for excellence in patient care, research, and clinical innovation. rngen is in the process of partnering with Mayo researchers and clinicians through its SBIR grant program to advance therapies across multiple disease areas.
View More
Investor & Funding
-
x
Wisconsin Economic Development Corporation
The Wisconsin Economic Development Corporation is the state’s lead economic agency, advancing business growth and innovation across Wisconsin. Provided operational support and early-stage financing to rngen through strategic loan programs.
View More -
x
Center for Technology Commercialization
The Center for Technology Commercialization supports Wisconsin-based companies by helping researchers and entrepreneurs bring innovations to market. They have provided matching funds to support rngen’s NIH SBIR grants through the state’s competitive commercialization program.
View More -
x
National Institute of Neurological Disorders and Stroke
The National Institute of Neurological Disorders and Stroke leads NIH efforts to reduce the burden of neurological disease through research and innovation. Provides SBIR funding to rngen for development of novel therapies in stroke and multiple sclerosis.
View More -
x
National Heart, Lung, and Blood Institute
The National Heart, Lung, and Blood Institute is a major NIH institute focused on advancing research in cardiovascular, pulmonary, and hematologic diseases. Supports rngen’s SBIR-funded programs targeting SCD and BPD.
View More -
x
Bridge to Cures
Bridge to Cures is a Wisconsin-based accelerator supporting early-stage academic entrepreneurs developing innovative healthcare solutions. Served as rngen’s initial investor, providing seed-stage funding to launch its therapeutic development platform.
View More -
x
gener8tor gBETA
gBETA is a nationally ranked startup accelerator offering intensive participatory programs to help early-stage companies gain traction and visibility. Supported rngen by facilitating access to venture capital, private equity, and angel investors.
View More
The partners graphic is not available on a mobile device. For details please view through a larger screen.